Zilver PTX

DEVICE3 trials

Sponsors

Flanders Medical Research Program, Nantes University Hospital, Rigshospitalet, Denmark

Conditions

Femoropopliteal LesionsPeripheral Arterial DiseasePeripheral Vascular Disease

Phase 4

The Cook Zilver PTX Drug-eluting Stent Versus Bypass Surgery for the Treatment The Cook Zilver PTX Drug-eluting Stent Versus Bypass Surgery of Femoropopliteal TASC C&D Lesions

Flanders Medical Research ProgramPeripheral Vascular Disease

Start: 2014-08-31End: 2019-12-31Target: 220Updated: 2018-03-06

Paclitaxel Eluting Stent or Exercise for Thigh Atherosclerosis

Rigshospitalet, DenmarkPeripheral Arterial Disease

Start: 2012-06-30End: 2017-08-31Target: 84Updated: 2014-01-10

Unknown Phase

BATTLE Trial: Bare Metal Stent Versus Paclitaxel Eluting Stent in the Setting of Primary Stenting of Intermediate Length Femoropopliteal Lesions

TerminatedNCT02004951

Nantes University HospitalFemoropopliteal Lesions, Peripheral Arterial Disease

Start: 2014-03-25End: 2020-08-07Updated: 2021-02-08

Related Papers

ZILVERPASS Study: ZILVER PTX Stent vs. Bypass Surgery in Femoropopliteal Lesions, 3 year results and economic analysis.

2023-05-101 citations

ZILVERPASS Study: ZILVER PTX Stent vs Bypass Surgery in Femoropopliteal Lesions

Journal of Endovascular Therapy2020-01-3065 citations

Bare metal stent versus paclitaxel eluting stent for intermediate length femoropopliteal arterial lesions (BATTLE trial): study protocol for a randomized controlled trial

Trials2014-10-3014 citations